NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

Public

Last Round

M&A

Feb 17, 2026

Est. Valuation

$368.32M

Total Funding Raised

$292M

Company Overview

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company that develops precision therapies and nutritional interventions for cancer treatment.

Sector

Biotech

Verticals

Life Sciences, Oncology

AI Layer

Infrastructure

Keywords

precision oncologymetabolic therapycancer metabolismnutrient controldrug discoveryMetabOScomputational biologysolid tumor therapymetabolic interventioncancer researchbiotechmetabolic medicinenutritional oncologyclinical trialscancer starvation

Faeth Therapeutics, Inc. Comps

Public and private peers based on sector, stage, and business model.

Faeth Therapeutics, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Faeth Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AFeb 17, 2026
VC RoundOct 20, 2025
Series AJun 30, 2022
SeedJan 18, 2022

Key People

Founding team and executive leadership

Anand Parikh

Chief Executive Officer Founder

Founding Team

Faeth Therapeutics, Inc. Investors

Notable investors and investment history

Faeth Therapeutics, Inc. investors
InvestorRounds
Balyasny Asset Management L.P.M&A
RA Capital ManagementM&A
Future VenturesSeries A, VC Round, Seed
Columbia Threadneedle InvestmentsM&A
Fairmount Funds ManagementM&A
Digitalis VenturesSeries A, VC Round, Seed
B Capital GroupVC Round

Faeth Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Faeth Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersAustin, Texas
Employee Range34
Year Founded2019
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.